PURPOSE: To summarize and compare the most recent data from the literature to clarify the management of male breast cancer. METHODS: A review article. RESULTS: Diagnosis and Treatment of Male Breast Cancer have been derivative for years. Nowadays MBC is a nosological entity in its own right with biological, molecular and clinical features that require a multidisciplinary approach and the involvement of specific skills. Multimodal treatment involves surgery, radiotherapy and chemotherapy. It is evident that the outcome of the MBC is worse than the female one. MBC is often diagnosed in advanced stages. Screening programs in the male population need to be strengthened to obtain an earlier diagnosis. It is necessary to know even more in depth the endocrine-metabolic and behavioral risk factors related to the neoplasm. Finally in the coming years it is reasonable to expect an improvement in multigenic tests: the sensitivity of these methods could predict the risk of recurrence even more precisely. This could lead to substantial changes in the choice and duration of treatment with results that could be surprising. KEY WORDS: Male breast cancer, Management, Review, Update.
Male breast cancer: an update / Benassai, G.; Miletti, A.; Calemma, F.; Furino, E.; De Palma, G. D.; Quarto, G.. - In: ANNALI ITALIANI DI CHIRURGIA. - ISSN 2239-253X. - 91:(2020), pp. 359-365.
Male breast cancer: an update
Benassai G.
;Miletti A.;Calemma F.;Furino E.;De Palma G. D.;Quarto G.
2020
Abstract
PURPOSE: To summarize and compare the most recent data from the literature to clarify the management of male breast cancer. METHODS: A review article. RESULTS: Diagnosis and Treatment of Male Breast Cancer have been derivative for years. Nowadays MBC is a nosological entity in its own right with biological, molecular and clinical features that require a multidisciplinary approach and the involvement of specific skills. Multimodal treatment involves surgery, radiotherapy and chemotherapy. It is evident that the outcome of the MBC is worse than the female one. MBC is often diagnosed in advanced stages. Screening programs in the male population need to be strengthened to obtain an earlier diagnosis. It is necessary to know even more in depth the endocrine-metabolic and behavioral risk factors related to the neoplasm. Finally in the coming years it is reasonable to expect an improvement in multigenic tests: the sensitivity of these methods could predict the risk of recurrence even more precisely. This could lead to substantial changes in the choice and duration of treatment with results that could be surprising. KEY WORDS: Male breast cancer, Management, Review, Update.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
